FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndOperating expenses (Million JPY)YoY (%)
Mar 31, 20252,925-25.20%
Mar 31, 20243,910-15.41%
Mar 31, 20234,623+20.01%
Mar 31, 20223,852-9.90%
Mar 31, 20214,275-12.53%
Mar 31, 20204,887+4.22%
Mar 31, 20194,689-7.13%
Mar 31, 20185,049-8.87%
Mar 31, 20175,541+19.58%
Mar 31, 20164,633+61.71%
Mar 31, 20152,865
AI Chat